[ad_1]
After including the CoronaVac vaccine as one of the probable immunize that will integrate the National Immunization Plan (PNI) against covid-19, the Ministry of Health announced this Tuesday (12/22) that it intends to more than double the Institute’s production offer Butantan, in association with the Chinese company Sinovac.
Medeiros explained that, initially, the contract closed with Butantan provides for the delivery of 46 million doses of Coronavac, nine million in January, 15 million in February and 22 million in March.
“We would have this delivery schedule proposed by Butantan, but yesterday (Monday) we had a meeting to expand this purchase to 100 million at the end of the first semester. The contract is in the final stage of liquidation, ”he said.
The Post contacted the Butantan Institute to confirm the extension of the contract with the Ministry of Health, but the entity did not respond until the publication of this report.
Pfizer
As in the case of Butantan, the agreement for the purchase of 70 million doses of the candidate from Pfizer will be finalized in “a matter of days”, as Medeiros guaranteed during his participation in the External Commission to Face Covid-19 in the Chamber of Deputies. “There is an expectation of delivering 8 million doses in the first half and 62 million doses starting in the second half.”
In addition, there is an agreement with AstraZeneca, with the production of the immunizer by the Oswaldo Cruz Foundation (Fiocruz). The federal government plans to incorporate 100.4 million doses of the vaccine in the first half of 2021. There is also a forecast of 42.5 million doses provided by the multilateral mechanism Covax Facility, in addition to agreements with the pharmaceutical companies Bharat Biotech, Moderna, Gamaleya and Janssen.
